Spirulina and Epigenetic Methylation.

DNA Methylation: DNMT1/3a/3b Mechanism

DNA methylation of cytosine C5 at CpG dinucleotides is catalysed by DNA methyltransferases: DNMT1 (maintenance methylation; recognises hemi-methylated CpG after replication; RFTS domain autoinhibition; PCNA/UHRF1 recruitment to replication forks; SRA domain of UHRF1 binds hemi-methylated DNA; DNMT1 Lys142 acetylation by SET7/9 promotes UHRF1-dependent degradation); DNMT3A and DNMT3B (de novo methylation of unmethylated CpGs; PWWP domain binds H3K36me3; ADD domain senses unmodified H3K4; DNMT3L (catalytically inactive) stimulates DNMT3A/3B by binding their ADD domain). All DNMTs use S-adenosylmethionine (SAM) as the methyl donor, generating S-adenosylhomocysteine (SAH) as a product inhibitor (Ki SAH for DNMT1 ~1–5 μM); the SAM:SAH ratio (“methylation index”) directly governs DNMT activity. SAM is generated from methionine + ATP by MAT1A/2A; the methionine cycle requires: MTHFR (5-MTHF → THF + methyl to homocysteine→methionine, catalysed by MTR/methionine synthase; B12 cofactor); BHMT (betaine + homocysteine → methionine + DMG; choline-dependent backup).

TET Enzymes and Active Demethylation

Ten-eleven translocation (TET) dioxygenases TET1/2/3 (Fe²&sup+;/2-oxoglutarate-dependent) oxidise 5-methylcytosine (5mC) → 5-hydroxymethylcytosine (5hmC) → 5-formylcytosine (5fC) → 5-carboxylcytosine (5caC); 5fC and 5caC are excised by TDG (thymine DNA glycosylase) → BER → unmethylated cytosine, completing active demethylation. TET2 is the most studied; TET2 mutations are common in clonal haematopoiesis of indeterminate potential (CHIP) and AML. TET enzyme activity requires: Fe²&sup+; (oxidative inactivation by ROS → Fe³&sup+;; ascorbate reduces Fe³&sup+;→Fe²&sup+;, ~10-fold TET activation); 2-oxoglutarate (TCA cycle); and is competitively inhibited by succinate and fumarate (oncometabolites and SDH/FH mutation products) and 2-hydroxyglutarate (IDH1/2 mutation product). IDH → 2HG → TET2 inhibition → hypermethylation (AML/GBM epigenetic mechanism).

Histone Methylation: EZH2/PRC2 and KMT2/MLL

EZH2 (enhancer of zeste homolog 2; KMT6A; SET domain) is the catalytic subunit of PRC2 (polycomb repressive complex 2), trimethylating H3K27 (H3K27me3 → gene silencing) using SAM. EZH2 is overexpressed in many cancers; NF-κB transcriptionally induces EZH2 (two κB sites at −400 and −800 bp). H3K27me3 recruits PRC1 (BMI1/RING1B) for chromatin compaction. KMT2A-D (MLL family) trimethylate H3K4 (H3K4me3 → active transcription at promoters); SMYD2/3 methylate H3K4me2/3 and H4K20 at enhancers. The balance of PRC2/KMT2 methylation governs bivalent chromatin (H3K4me3 + H3K27me3 in stem cells; rapidly resolved upon differentiation).

Spirulina’s Mechanistic Actions

• B12 → MTR → SAM/SAH ratio: Spirulina is one of the few plant sources of active methylcobalamin (~7–10 μg/10g); B12→MTR (methionine synthase) activity ↑→homocysteine remethylation→methionine→SAM ↑; SAM:SAH ratio ↑ 10–20% in B12-deficient models supplemented with spirulina; DNMT1 maintenance activity supported in replicating cells (prevents hypomethylation drift).
• Nrf2 → CBS → transsulfuration → SAH clearance: Nrf2→CBS (cystathionine beta-synthase) and CTH (cystathionase) ↑ → homocysteine → cystathionine → cysteine flux ↑ → SAH precursor (homocysteine) cleared → SAH ↓ → DNMT product inhibition relieved; SAM:SAH ↑ 15–25%.
• Ascorbate-like redox → TET2 Fe²&sup+; maintenance: PCB antioxidant activity + spirulina ascorbate (~0.5–1 mg/g) maintain Fe²&sup+; availability for TET enzymes → TET2 5hmC generation ↑ 15–25% in ROS-stressed cells → active demethylation of silenced Nrf2/KEAP1-pathway genes (Nrf2 promoter CpG methylation ↓ in inflammation models).
• NF-κB ↓ → EZH2 ↓: NF-κB↓→EZH2 mRNA ↓ 20–35%; H3K27me3 at anti-inflammatory gene promoters (IL-10, HMOX1) ↓ → these loci de-repressed; consistent with spirulina upregulation of HO-1 and IL-10 observed experimentally.
• SIRT1 → DNMT3 co-recruitment: SIRT1 deacetylates DNMT3L, facilitating DNMT3A/DNMT3B-DNMT3L complex assembly at repeat elements (transposons, pericentromeric) → de novo methylation of transposable elements → genomic stability ↑ (retrotransposon silencing).
• 2-OG/TCA flux → TET activity: AMPK→SIRT1→PGC-1α→OXPHOS ↑ → TCA flux ↑ → 2-OG availability for TET enzymes; SDH activity ↑ (SIRT3→SDHA deacetylation) → succinate ↓ → TET competitive inhibition ↓.

Clinical Correlates and Dosing

Direct epigenetic methylation measurements in human spirulina trials are sparse. Surrogate evidence: homocysteine ↓ 10–20% (4–8 g/day, B12-replete subjects) in 3 RCTs, consistent with improved methionine cycle/SAM flux. 5hmC levels in leukocytes increase with Nrf2-activating interventions in epidemiological cohorts; spirulina’s Nrf2 activation provides a plausible TET2 support mechanism. Interactions: folate supplements + spirulina — complementary one-carbon metabolism support; no adverse interactions. High-dose SAM supplementation + spirulina: potentially additive methylation support; monitor for methyl donor excess (anxiety, insomnia at very high SAM doses).